том 70 издание 2 страницы 100-112

The Discovery of (2R,4R)-N-(4-chlorophenyl)-N- (2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidine-1,2-dicarboxamide (PD 0348292), an Orally Efficacious Factor Xa Inhibitor

Тип публикацииJournal Article
Дата публикации2007-08-01
SCImago Q2
WOS Q2
БС2
SJR0.666
CiteScore5.6
Impact factor3.3
ISSN17470277, 17470285
Organic Chemistry
Drug Discovery
Biochemistry
Pharmacology
Molecular Medicine
Краткое описание
Herein, we report the discovery of novel, proline-based factor Xa inhibitors containing a neutral P1 chlorophenyl pharmacophore. Through the additional incorporation of 1-(4-amino-3-fluoro-phenyl)-1H-pyridin-2-one 22, as a P4 pharmacophore, we discovered compound 7 (PD 0348292). This compound is a selective, orally bioavailable, efficacious FXa inhibitor that is currently in phase II clinical trials for the treatment and prevention of thrombotic disorders.
Для доступа к списку цитирований публикации необходимо авторизоваться.

Топ-30

Журналы

1
2
3
4
5
Molecules
5 публикаций, 13.51%
Journal of Medicinal Chemistry
4 публикации, 10.81%
European Journal of Medicinal Chemistry
3 публикации, 8.11%
Thrombosis and Haemostasis
3 публикации, 8.11%
Bioorganic and Medicinal Chemistry Letters
2 публикации, 5.41%
Expert Opinion on Investigational Drugs
2 публикации, 5.41%
Acta Crystallographica Section E Structure Reports Online
1 публикация, 2.7%
Arteriosclerosis, Thrombosis, and Vascular Biology
1 публикация, 2.7%
Nature Reviews Cardiology
1 публикация, 2.7%
Drugs
1 публикация, 2.7%
Nature Reviews Drug Discovery
1 публикация, 2.7%
Chemical Papers
1 публикация, 2.7%
Bioorganic and Medicinal Chemistry
1 публикация, 2.7%
Journal of Thrombosis and Haemostasis
1 публикация, 2.7%
Angewandte Chemie
1 публикация, 2.7%
Angewandte Chemie - International Edition
1 публикация, 2.7%
Medicinal Research Reviews
1 публикация, 2.7%
Chemistry - A European Journal
1 публикация, 2.7%
Expert Review of Hematology
1 публикация, 2.7%
Annual Reports in Medicinal Chemistry
1 публикация, 2.7%
Hamostaseologie
1 публикация, 2.7%
Seminars in Thrombosis and Hemostasis
1 публикация, 2.7%
Journal of the American Chemical Society
1 публикация, 2.7%
1
2
3
4
5

Издатели

1
2
3
4
5
6
7
Elsevier
7 публикаций, 18.92%
MDPI
5 публикаций, 13.51%
Wiley
5 публикаций, 13.51%
American Chemical Society (ACS)
5 публикаций, 13.51%
Georg Thieme Verlag KG
5 публикаций, 13.51%
Springer Nature
4 публикации, 10.81%
Taylor & Francis
3 публикации, 8.11%
International Union of Crystallography (IUCr)
1 публикация, 2.7%
Ovid Technologies (Wolters Kluwer Health)
1 публикация, 2.7%
1
2
3
4
5
6
7
  • Мы не учитываем публикации, у которых нет DOI.
  • Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
 Войти с ORCID
Метрики
37
Поделиться
Цитировать
ГОСТ |
Цитировать
Kohrt J. T. et al. The Discovery of (2R,4R)-N-(4-chlorophenyl)-N- (2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidine-1,2-dicarboxamide (PD 0348292), an Orally Efficacious Factor Xa Inhibitor // Chemical Biology and Drug Design. 2007. Vol. 70. No. 2. pp. 100-112.
ГОСТ со всеми авторами (до 50) Скопировать
Kohrt J. T., Bigge C. F., BRYANT J. W., Casimiro-Garcia A., Chi L., Cody W. L., Dahring T., Dudley D. A., Filipski K. J., Haarer S., Heemstra R., Janiczek N., Narasimhan L., Mcclanahan T., Peterson J. T., Sahasrabudhe V., Schaum R., Van Huis C. A., Welch K. M., Zhang E., Leadley R. J., Edmunds J. J. The Discovery of (2R,4R)-N-(4-chlorophenyl)-N- (2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidine-1,2-dicarboxamide (PD 0348292), an Orally Efficacious Factor Xa Inhibitor // Chemical Biology and Drug Design. 2007. Vol. 70. No. 2. pp. 100-112.
RIS |
Цитировать
TY - JOUR
DO - 10.1111/j.1747-0285.2007.00539.x
UR - https://doi.org/10.1111/j.1747-0285.2007.00539.x
TI - The Discovery of (2R,4R)-N-(4-chlorophenyl)-N- (2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidine-1,2-dicarboxamide (PD 0348292), an Orally Efficacious Factor Xa Inhibitor
T2 - Chemical Biology and Drug Design
AU - Kohrt, Jeffrey T
AU - Bigge, Christopher F.
AU - BRYANT, JOHN W.
AU - Casimiro-Garcia, Agustin
AU - Chi, Liguo
AU - Cody, Wayne L.
AU - Dahring, Tawny
AU - Dudley, Danette A
AU - Filipski, Kevin J
AU - Haarer, Staci
AU - Heemstra, Ron
AU - Janiczek, Nancy
AU - Narasimhan, Lakshmi
AU - Mcclanahan, Thomas
AU - Peterson, J. Thomas
AU - Sahasrabudhe, Vaisheli
AU - Schaum, Robert
AU - Van Huis, Chad A
AU - Welch, Kathleen M.
AU - Zhang, Erli
AU - Leadley, Robert J.
AU - Edmunds, Jeremy J
PY - 2007
DA - 2007/08/01
PB - Wiley
SP - 100-112
IS - 2
VL - 70
PMID - 17683371
SN - 1747-0277
SN - 1747-0285
ER -
BibTex |
Цитировать
BibTex (до 50 авторов) Скопировать
@article{2007_Kohrt,
author = {Jeffrey T Kohrt and Christopher F. Bigge and JOHN W. BRYANT and Agustin Casimiro-Garcia and Liguo Chi and Wayne L. Cody and Tawny Dahring and Danette A Dudley and Kevin J Filipski and Staci Haarer and Ron Heemstra and Nancy Janiczek and Lakshmi Narasimhan and Thomas Mcclanahan and J. Thomas Peterson and Vaisheli Sahasrabudhe and Robert Schaum and Chad A Van Huis and Kathleen M. Welch and Erli Zhang and Robert J. Leadley and Jeremy J Edmunds},
title = {The Discovery of (2R,4R)-N-(4-chlorophenyl)-N- (2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidine-1,2-dicarboxamide (PD 0348292), an Orally Efficacious Factor Xa Inhibitor},
journal = {Chemical Biology and Drug Design},
year = {2007},
volume = {70},
publisher = {Wiley},
month = {aug},
url = {https://doi.org/10.1111/j.1747-0285.2007.00539.x},
number = {2},
pages = {100--112},
doi = {10.1111/j.1747-0285.2007.00539.x}
}
MLA
Цитировать
Kohrt, Jeffrey T., et al. “The Discovery of (2R,4R)-N-(4-chlorophenyl)-N- (2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidine-1,2-dicarboxamide (PD 0348292), an Orally Efficacious Factor Xa Inhibitor.” Chemical Biology and Drug Design, vol. 70, no. 2, Aug. 2007, pp. 100-112. https://doi.org/10.1111/j.1747-0285.2007.00539.x.
Ошибка в публикации?